Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • fadista
    Member
    • Sep 2008
    • 37

    MAQ mapping quality scores

    Hi,

    Just want to be sure about the MAQ mapping qualities.

    I have a lot of reads with the mapping quality of 99. Is this the Phred-scaled probability that the read alignment is wrong? And if so, the reads with mapping quality of 99 will have a probability of being wrong equal to p = 10 ^(-90/10) = 1e-09 right?
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    That is my understanding. I am still confused a bit as there is some discussion in the comments of some parts of maq that there is 10 added to the mapping qualities in some parts.

    Maybe lh3 will chime in if he sees this.

    Comment

    • zee
      NGS specialist
      • Apr 2008
      • 249

      #3
      As far as I understand the mapping quality score is related to:

      1) sequence quality of the aligned read
      2) number of locations the sequence maps to

      Ih3 is best qualified to give a more comprehensive answer.
      If your score distribution is skewed to 99 then you either have very high quality data or perhaps there is a bias for a particular region that was sequenced from the sample.
      AFAIK MAQ assigns a quality of zero to randomly chosen matches, so I think it's unlikely that your 99 mapped to multiple loci. Do you observe a similar score distribution with other aligners?
      Last edited by zee; 09-30-2008, 04:47 AM.

      Comment

      • Layla
        Member
        • Sep 2008
        • 58

        #4
        This is a very interesting problem. I have run maq match and see that 82% of my reads are correctly paired. Secondly, 40% of my reads have a mapping quality of 0 and thus mean these reads have multiple hits. Thirdly only 2% of my reads have a mapping quality of 30 (error 0.001). However, the mapping quality values range from 30 to 99. What do these represent? Are they considered reliable and hence kept for further analysis?
        Any help or advice/discussion would be very useful.

        L

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        34 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        217 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        81 views
        0 reactions
        Last Post SEQadmin2  
        Working...